FDA Approves First ALS Drug in 5 Years After Pleas From Patients
But Jinsy A. Andrews, an associate professor of neurology and director of neuromuscular clinical trials at Columbia University, who is also an investigator in the large trial underway for the drug, applauded the approval and said she plans to start prescribing the drug as soon as it is available. “I see patients living with this disease, and I diagnose them every day,” Andrews said. “So to have another therapy for the tool kit is helpful.” [read more]
Source: The Washington Post
Editor's Note: This story was also covered by Reuters.